SearchDictionaryMobileLogin

Beta-Globulins (Beta-Globulin)

144  relevant articles (3 outcomes, 6 trials/studies) found for this Bio-Agent

Description: Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.

Also Known As:
Beta-Globulin; Beta(1)CA Globulin; Beta Globulin; Beta Globulins

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Okimoto, Niro: 1 article (03/2002)
2. Honda, Yoshihiro: 1 article (03/2002)
3. Nakamura, Junichi: 1 article (03/2002)
4. Asaoka, Naoko: 1 article (03/2002)
5. Fujita, Kazue: 1 article (03/2002)
6. Ohba, Hideo: 1 article (03/2002)
7. Soejima, Rinzo: 1 article (03/2002)

Related Diseases

1. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
2. Body Weight (Weight, Body)
01/01/1976 - "At the end of the experiment, the greatest differences between the treated and control ponies were in the mean number of worm eggs in fecal samples (0 vs 1,866 eggs/g), mean body weight (151.9 vs 117.0 kg), mean heart girth (126.5 vs 116.3 cm), mean packed cell volume (36.4 vs 30.8%), and mean serum protein content (8.47 vs 9.33 mg/100 ml), especially beta-globulin content (mean of 1.9 vs 3.4 mg/100 ml). "
02/01/1986 - "The 0.50 mg/kg dose of vomitoxin resulted in significantly reduced serum levels of alpha 2- and beta-globulins while a significant reduction of feed consumption was evident only during Week 4. Similarly, body weight gain in this group of mice was significantly reduced during Week 2 but increased to normal levels during Week 3 and remained parallel to the control for Week 4 and 5. Both levels (0.50 and 1.00 mg/kg) of vomitoxin resulted in a reduced, dose-related, time-to-death interval following a challenge with L. "
08/01/2006 - "The ERMBT data correlated with body weight, alpha- and beta-globulins and alanin aminotransferases (0.10 < r(s) < 0.20; P < 0.01). "
01/01/1982 - "Small and similar variability occurred in hematocrit value and beta-globulins while higher variability occurred in body weight and gamma-globulins. "
01/01/1982 - "1. Heterozygotes TfF/TfE of voles did not differ in body weight, they had higher hematocrit value (males and females), higher beta-globulin fraction (males) or higher gamma-globulin fraction (females). "
Order ALL the reference details at left...
3. Carcinoma (Carcinomatosis)
4. Neoplasms (Cancer)
5. Infection

Related Drugs and Biologics

1. gamma-Globulins (gamma-Globulin)
2. Immunoglobulin G (IgG)
3. Lactoferrin
4. Immunoglobulin A (IgA)
5. Immunoglobulin M (IgM)
6. Caseins (Casein)
7. deoxynivalenol
8. Proteins (Proteins, Gene)
9. Antigens
10. DNA Probes

Related Therapies and Procedures

1. X-Ray Film
2. Nephrectomy

Best Treatments:
Research Summary Report
on Prostatic Hyperplasia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 387 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>